BASF & vitamin C
This article was originally published in The Tan Sheet
Executive Summary
Company to shut down crystalline vitamin C line at Wilmington, N.C. facility by July 2002 but will continue to run vitamin C granulating, packaging operations at the site, ingredient supplier says Nov. 15. Move is aimed at strengthening BASF's market position by concentrating vitamin C manufacturing efforts "on areas that deliver better cost competitiveness and economies of scale," company says. BASF acquired the Wilmington site in January through its purchase of Takeda Chemical Industries' bulk vitamin business (1"The Tan Sheet" Aug. 7, 2000, p. 9)...
You may also be interested in...
BASF Global Vitamin Presence Strengthened With Takeda Combination
BASF's agreement to combine its bulk vitamins business with that of Takeda Chemical Industries considerably strengthens the chemical giant's position in the global vitamins market.
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.